The Trump Administration issued a notice on Monday titled, “Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients,” which could serve...more
4/17/2025
/ Imports ,
International Emergency Economic Powers Act (IEEPA) ,
International Trade ,
National Security ,
Pharmaceutical Industry ,
Public Comment ,
Regulatory Requirements ,
Section 232 ,
Supply Chain ,
Tariffs ,
Trump Administration
On Wednesday, April 2, 2025, President Donald Trump held a press conference to describe and sign an Executive Order (EO) establishing sweeping “reciprocal tariffs” on nearly all imports to the US, as outlined below....more